Expert Panel: Role of Genomics and Genetics in Prostate Cancer
 |
| Expert Panel: Role of Genomics and Genetics in Prostate Cancer Christopher Lee, MD; Alvaro Martinez, MD; Daniel Kim, MD, MBA; Steven E. Finkelstein, MD; and Dwight E. Heron, MD, MBA, FACRO, FACR, discuss how genomic and genetic research is revolutionizing our understanding of prostate cancer risk, progression, personalized treatment strategies, and potential targeted interventions by identifying specific genetic markers, inherited mutations, and molecular pathways that influence disease development and patient outcomes. Watch Now |
|
Featured Video |
 |
| Precision Active Surveillance: Leveraging Genomic Testing and CCR Scores in Prostate Cancer Management Daniel Kim, MD, MBA discusses how genomic testing has revolutionized patient selection for active surveillance by integrating molecular insights that transcend traditional clinical parameters, enabling more nuanced risk stratification and personalized management of intermediate-risk prostate cancer. Watch Now |